Logo

Pentabase Receives $339K from Angel Investor

Nov 18, 2008
NEW YORK (GenomeWeb News) – Odense, Denmark-based PentaBase has received DKK 2 million (US$339,000) from an unnamed angel investor, the firm said this week.
 
PentaBase, which is developing molecular diagnostics and sells real-time PCR-based probes, said that the funding will be used to increase sales of its platform technologies, services, and diagnostic tests for infectious diseases. The firm also offers DNA sequencing services.
 
PentaBase said that the funding came from an anonymous Danish business investor, “who previously [had] experienced similar challenges to those that PentaBase currently have.”
 
“This funding will primarily be used to increase our sales activities of existing products and the development and protection of our patent portfolio,” PentaBase Founder and CEO Ulf Bech Christensen said in a statement.
 
Pentabase was founded in 2006 and is developing diagnostic tools for influenza, avian flu, and cancer-related diseases.

Breaking News
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.